Research Divisions

Environmental and Molecular Epidemiology of Cancer

Group LeaderLocation and ContactMembersHistory of the GroupLines of ResearchNotable PublicationsProjectsPhD ThesesClinical TrialsNews
Professor Adonina Tardón García
Professor Adonina Tardón García

Professor in Preventive Medicine and Public Health, Universidad de Oviedo.

ORCID ID: 0000 0001 5150 1209

Adonina Tardón has a PhD in Medicine and Surgery; she is a specialist in Preventive Medicine and Public Health, a member of the Cuerpo Médico de Sanidad Nacional (National Health Medical Corps) and a Professor in Preventive Medicine and Public Health at the Universidad de Oviedo.

She has extensive university teaching experience at undergraduate and postgraduate level. She has led the teaching programme on Preventive Medicine and Public Health at the Universidad de Oviedo since 1 September 2016. She has supervised 24 research dissertations and Diplomas of Advanced Studies on the Cancer Research (15) and Diagnosis in Community Health (9) programmes. She has supervised nine dissertations on the Master’s degrees in Biomedicine and Molecular Oncology; Occupational Risk Prevention, and Emergency and Disaster Analysis and Management.

Over the last five years, she has supervised eight PhD theses on the Diagnosis in Community Health and Cancer Research programmes. Two of these theses received the Universidad de Oviedo outstanding PhD award and one received international honours.

She was Scientific Secretary of the Instituto Universitario de Oncología del Principado de Asturias (IUOPA) in the Universidad de Oviedo from January 2000 to September 2016, and has led IUOPA’s Environmental and Molecular Epidemiology research group since January 2000.

Since January 2007, she has been head of research group 53 in CIBERESP (Network Centre for Biomedical Research: Epidemiology and Public Health), where she has been administrative coordinator of programme five and a member of the CIBERESP Management Committee since January 2011.

Finally, in July 2017, she was selected to join ISPA as principal investigator of this consolidated research group.

She is author of 266 scientific articles in journals with international-level impact, her H-index is 41 and she has a total of 5,785 citations: 1400 in bladder cancer, 300 in lung cancer and 1254 in the field of childhood and environment. She has received funding for three six-year research periods, and has secured 20 funded research projects from national and international agencies. Additionally, she has secured and completed ten private-sector contracts for consultancy and the production of epidemiological reports and assessments. In January 2017, she entered into a partnership with the Consejería de Sanidad del Principado de Asturias to carry out knowledge transfer activities related to the COHORTE INMA Asturias (Asturian Child and Environment Cohort) study of the Universidad de Oviedo .

Member of the Comité de Ética de la Investigación del Principado de Asturias) (Research Ethics Committee of Asturias). Appointment through Consejería de Sanidad Resolution of 23 April 2014; the post is ongoing.

Member of the Comité de Ética de la Universidad de Oviedo (University of Oviedo Ethics Committee). Appointment on 13 April 2018; the post is ongoing.

Member of the Ponencia Técnica de Cáncer Laboral (Technical Platform on Occupational Cancer). Comité de Cáncer del Principado de Asturias (Cancer Committee of Asturias). Appointment on 25 March 2015; the post is ongoing.

Área de Medicina Preventiva y Salud Pública.

Facultad de Medicina y Ciencias de la Salud. Universidad de Oviedo.

Campus del Cristo s/n, Oviedo, Spain. Offices D4-10.

Telephone: 985103545 | 985102758

E-mail: atardon@uniovi.es

Name Organisation Activity Euraxess classification
Arcos González, Pedro Ignacio Universidad de Oviedo Research/Teaching R3
Castro Delgado, Rafael Vicente Universidad de Oviedo Research/Clinical/Teaching R3
Fernández Iglesias, Rocío CIBER Research/Teaching R1
Fernández Somoano, Ana Universidad de Oviedo Research/Teaching R3
Fernández Tardón, Guillermo Universidad de Oviedo Research/Teaching R1
Riaño Galán, Isolina SESPA/Universidad de Oviedo Research/Clinical/Teaching R2
Rivas del Fresno, Manuel SESPA Research/Clinical R2
Rodríguez Dehli, Ana Cristina SESPA Research/Clinical R2
Tardón García, Adonina Universidad de Oviedo Research/Teaching R4
Arias Díaz, María Cristina Universidad de Oviedo Research No classification
Arias Fernández, María Asunción Fundación de Investigación Oftalmológica (FIO) Research No classification

The Molecular and Environmental Epidemiology research group is part of the Instituto Universitario de Oncología (IUOPA) in the Universidad de Oviedo, and operates within the Preventive Medicine and Public Health section of the Faculty of Medicine and Health Sciences.

It has a history of over 20 years of collaborative work. Since 1997, the group’s scientific work has focused on the following fields: occupational and molecular epidemiology and the genetic epidemiology of cancer – particularly lung and bladder cancer – (CAPUA Study, Spanish Bladder Cancer, MCC Spain); environmental epidemiology (COHORTE INMA Asturias); mortality in small areas of Spain (MEDEA Group); emergencies, disasters, climate change, emergent diseases and epidemiological analysis of environmental epidemiology.

We are the research group for Asturias in the Spanish Bladder Cancer study, conducted in partnership with the NIH’s National Cancer Institute in the US. This epidemiological study of bladder cancer is the most extensive and productive of its kind in Spain, having generated over 65 articles on a range of issues related to the development of bladder cancer in several journals of international prestige.

The group was responsible for designing and setting up the Universidad de Oviedo’s CAPUA (Lung Cancer in Asturias) Study which has received funding from national and international agencies and has resulted in the publication of 42 scientific articles, 75% of which appeared in first-quartile journals. It forms part of the INTERNATIONAL LUNG CANCER CONSORTIUM, http://ilcco.iarc.fr/ and the IARC’s SYNERGY PROJECThttp://synergy.iarc.fr.

The research group represents Asturias in the the CIBERESP MCC-SPAIN multi-case-control study, http://www.mccspain.org which was designed in Spain to investigate the influence of environmental factors and how they interact with genetic factors in colorectal, breast, gastroesophageal and prostate cancer tumours. The study has produced 36 scientific articles to date, most in first-quartile journals.

The group is responsible for the Cohorte INMA Asturias (Asturian Child and Environment Cohort) study, in which a cohort of 12-week-old babies was established from the population of Asturian Health District III in 2004. To date, the cohort has been monitored up to 8 years of age, with a response rate of 92.41%. We are currently in the phase of monitoring up to 11 years of age . Research on the INMA Asturias cohort focuses on obesity and its repercussions in childhood, taking into account all exposures to risk since pregnancy. We have also been studying the presence and concentration of persistent toxic substances in the pregnant women and their children.

The research group is also responsible for the Universidad de Oviedo’s Emergency and Disaster Research Unit http://www.uniovi.net/uied, whose research is focused on public health during emergencies and disasters. We have developed the Advanced Off-site Triage Model , which is used by a number of the Spanish emergency services. We have conducted studies on how industrial activity impacts the population, climate change and disasters, as well as the epidemiology of disasters in a general sense. One of our current lines of research explores the impact of pollution by analysing emergency calls to an emergency control centre.

The group leads the Air Quality and Health Study, which was set up in partnership with the Dirección General de Salud Pública (General Office of Public Health) in 2016, in order to develop an Epidemiological Surveillance System for diseases related to air pollution in Asturias. We monitored indicators for health and air quality between 2003 and 2015 to explore the relationship between them, and thereby understand the negative effects of pollution on the health of the population. We have been continuing to study the time series from 2016 onwards, and aim to identify geographical patterns in the rates of emergency hospital admissions for heart attacks, angina, asthma and chronic obstructive pulmonary disease in the health districts of Oviedo, Gijón and Avilés.

We are the research group participating in the MEDEA Study for Asturias. The Mortality in Small Areas of Spain and Socio-Economic and Environmental Inequalities (MEDEA) project is a national, multi-centre study which aims to describe the geographic patterns in mortality in a range of different Spanish cities and relate these patterns to the socioeconomic and environmental characteristics of small areas (the project’s unit of analysis is the ‘sección censal’, or census tract). Since 2017, we have been leading the MEDEA3 project (the third phase of the project). In the current project phase, the aim is to study the aforementioned patterns and the causes of death in the main cities of Asturias, exploring certain issues that were not addressed earlier in the project, and continuing the task of monitoring mortality initiated in previous phases.

Strategic Objectives for the CAPUA Study in the Coming Years
  1. Draw conclusions on the interaction of environmental, genetic and occupational determinants in the development of lung cancer, so as to intervene in policy design aimed at preventing primary and secondary lung cancer, such as lung cancer screening, thereby engaging in scientific knowledge transfer and translation.
  2. Search for sensitivity markers to define the target population for a possible lung cancer screening and early-detection programme in Spain.
  3. Assess lung cancer exposure-response relationships. Contribute to knowledge about the genes associated with lung cancer. Study the interactions between genetics and environment in lung cancer, with the ultimate objective of identifying high-risk individuals and groups on whom early-detection efforts may be focused.
  4. Contribute to the discovery of genetic or epigenetic expression markers in lung cancer which can be transferred to clinical practice, in the form of markers for the development of new personalised and/or precision treatments for specific forms of lung cancer.
High-level Strategic Objectives for the COHORTE INMA Asturias study
  1. Describe the level of environmental pollution and children’s exposure during gestation and early childhood. Determine the role of the most prevalent environmental pollutants and protective factors related to diet during foetal growth and neuro-endocrine-immune development.
  2. Provide useful information for the creation of programmes involving environmental health indicators and risk assessment.
  3. Measure air pollution in Asturias and its effect on respiratory diseases and child development.
  4. Evaluate the extent to which persistent organic pollutants (POPs) are transferred from mother to newborn and their effect.
  5. Explore the role of the most significant environmental pollutants present in the air, water and diet during pregnancy and at the beginning of life, and their effects on children’s growth and development.
  6. Describe the combined effect of endocrine-disrupting environmental pollutants that are delivered primarily through food and drink on children, in relation to exposure during development, by using exposure bio-markers, and describe the connection of this phenomenon to obesity. Draw conclusions on the dietary factors associated with excess weight and obesity in the early years of a child’s life, describing and quantifying the factors associated with excess weight and obesity .
  7. Search for and develop predictive markers in children and mothers ( markers of exposure, effect and individual risk, as well as sensitivity markers). Study and evaluate markers of exposure, effect and individual risk in the child population for the purposes of prevention, transferring and translating this knowledge through the production of clinical and monitoring guides .
  8. Participate in the development of Public Health Guides intended to inform scientific policy and environmental legislation in Spain and Europe, thereby engaging in knowledge transfer and translation.
  9. Study the prevalence of vitamin D and its association with related pathologies.
  10. Analyse the association between lipid profile and weight in early childhood

Concerning metabolic syndrome and cardiovascular risk factors (CVRF):

  1. Study the association between exposure to environmental obesogenics during the prenatal and postnatal stages and the appearance of adverse effects involved in the development of obesity and metabolic syndrome in children and adolescents.
  2. Determine whether breastfeeding and a diet rich in antioxidants and fatty acid have a protective effect against the adverse effects involved in the development of CVRF, due to exposure to environmental pollutants.
Strategic Objectives for the MCC Spain Study – Asturias – in the Coming Years
  1. Assess the risk of cancer of each body location in relation to environmental and occupational exposure, including pollutants in tap water (arsenic, nitrates, chromium, chlorination byproducts), hormonal disruptors and other persistent organic pollutants, as well as the disruption of the circadian rhythm caused by work involving night shifts, and other factors.
  2. Assess the risk of cancer in relation to the consumption of certain drugs, including statins and painkillers.
  3. Assess the risk of cancer in relation to a range of factors, such as life style, nutrition and physical activity, an individual’s medical and familial history, and other factors.
  4. Assess the risk of breast and prostrate cancer in relation to hormonal factors, infections and permanent phenotypes that are connected to environmental exposure in the early life stages.
  5. Verify the assessment of exposure to environmental chemical agents through exposure models, using exposure biomarkers, individual information and environmental exposure measures.
  6. As an initial stage, assess a limited series of genes, in terms of their primary effects and their interaction with environmental factors.
  7. Store sufficient biological material for future use in genome wide association studies (GWAS), and other studies.
Strategic Objectives of the MEDEA Study in the Coming Years
  1. Describe the evolution of socioeconomic and environmental inequalities in mortality in geographical areas of Oviedo, Gijón and Avilés.
  2. Study the geographical distribution of mortality in the three main cities of Asturias (Oviedo, Gijón and Avilés), analysing socioeconomic inequalities at the scale of small geographic areas and estimating exposure to environmental factors using three sources: air quality measurements, sources of industrial pollutants and green areas (incorporated into the National MEDEA III Project).
  3. Analyse the trends in socioeconomic inequalities.
  4. Develop a composite socioeconomic index that enables inequalities to be recorded by gender.
  5. Describe the evolution of mortality inequalities in geographic areas of Spanish cities from 1996 to 2001 and from 2002 to 2007, taking into account gender inequalities.
  6. Analyse the relationship between mortality indicators and socioeconomic indicators for small geographic areas in two periods of time, taking into account gender inequalities.
  7. Analyse trends in environmental inequalities.
  8. Describe the spatial distribution of air pollution and exposure to vehicular traffic in geographic areas of Spanish cities and how it changed from 1996 to 2001 and from 2002 to 2007.
  9. Analyse the relationship between environmental variables – air pollution, proximity to roads and proximity to polluting industries, and mortality by census tracts.
  10. Examine how the sex, age and socioeconomic-status variables modify the effect of environmental variables upon mortality.
  11. Study how socioeconomic indicators and the effect of exposure to an industrial centre may interact with and modify each other.
  12. Perform space-time modelling.
  13. Produce a visualisation of the space-time evolution of mortality in the cities involved in the project for the 1996-2007 period, with a temporal breakdown by year.
  14. Explore possible methodological improvements in the space-time modelling of risks, using the AIDS model trialled in the city of Valencia in the MEDEA I project as a baseline.
Strategic Objectives for the Emergency and Disaster Research Unit
  1. Some of our most significant future research includes improving how health professionals respond to disasters, the impact of pollution and emergencies.
  2. Some of our key scientific challenges and strategic objectives include improving the education of health professionals on analysing and responding to disasters from a public health perspective, as well as standardising training.
Strategic Objectives of the Spanish Bladder Cancer Asturias Study and the PANKRAS Study

Maintain our collaboration with the Centro Nacional de Investigaciones Oncológicas (Spanish National Cancer Research Center) on analysing the results of the Spanish Bladder Cancer and PANKRAS studies.

Strategic Objectives of the Air Quality and Health Study

The objective of this project is to process and monitor data on air quality and health indicators, so as to design and implement an epidemiological surveillance system for diseases related to air pollution. Specifically, its objective is to investigate the association between air quality and health in Asturias.

Environmental risk factors, and poor air quality in particular, are an important public health problem attracting increasing interest, with a negative impact on people’s health: particularly the most vulnerable groups. Analysing the determinants of this problem and its impact on populations is complex and requires interdisciplinary collaboration. The challenge posed by this line of investigation is to develop a health and environmental information system that enables us to perform an epidemiological assessment of the association between air quality and health in Asturias.

  1. Perform epidemiological surveillance of the diseases related to air pollution in Asturias (in collaboration with the Consejería de Sanidad del Principado de Asturias: partnership and annual reports).
  2. By monitoring health and air quality indicators, study the relationships that exist between them in the 2003-2018 period, with the aim of understanding the negative effects of pollution upon the health of the population.
  3. Continue studying the time series from 2016 onwards, in order to identify geographical patterns in the rates of emergency hospital admissions for heart attacks, angina, asthma and chronic obstructive pulmonary disease in the health districts of Oviedo, Gijón and Avilés.
  4. Develop and coordinate the research design for the Human Exposome Project, so as to submit it to the European Horizon 2020 framework programme.
  1. AUTHORS: Riaño-Galán I, Fernández-Somoano A, Rodríguez-Dehli C, Valvi D, Vrijheid M, Tardón A.
    TITLE: Proatherogenic Lipid Profile in Early Childhood: Association with Weight Status at 4 Years and Parental Obesity.
    J Pediatr. 2017 Aug; 187:153-157.e2. doi: 10.1016/j.jpeds.2017.04.042. Epub 2017 May 18. PubMed PMID: 28529017
  2. AUTHORS: Costa O, Lopez-Espinosa MJ, Vizcaino E, Murcia M, Iñiguez C, Navarrete-Muñoz EM, Grimalt JO, Tardon A, Ballester F, Fernandez-Somoano A.
    TITLE: Dietary and Household Sources of Prenatal Exposure to Polybrominated Diphenyl Ethers (PBDEs) in the INMA Birth Cohort (Spain).
    Environ Sci Technol. 2016 Jun 7;50(11):5935-44. doi: 10.1021/acs.est.5b06263. Epub 2016 May 13. PubMed PMID: 27123793.
  3. AUTHORS: Rodríguez-Dehli AC, Riaño-Galán I, Fernández-Somoano A, Navarrete-Muñoz EM, M, Vioque J, Tardón A.
    TITLE: Hypovitaminosis D and associated factors in 4-year old children in northern Spain.
    An Pediatr (Barc). 2017 Apr;86(4):188-196. doi: 10.1016/j.anpedi.2016.02.003. Epub 2016 Mar 14. Spanish. PubMed PMID: 26988234.
  4. AUTHORS: Lopez-Espinosa MJ, Costa O, Vizcaino E, Murcia M, Fernandez-Somoano A, Iñiguez C, Llop S, Grimalt JO, Ballester F, Tardon A.
    TITLE: Prenatal Exposure to Polybrominated Flame Retardants and Fetal Growth in the INMA Cohort (Spain).
    Environ Sci Technol. 2015 Aug 18;49(16):10108-16. doi: 10.1021/acs.est.5b01793. Epub 2015 Aug 4. PubMed PMID: 26181825; PubMed Central PMCID: PMC4573079.
  5. AUTHORS: Fernández-Somoano A, Llop S, Aguilera I, Tamayo-Uria I, Martínez MD, Foraster M, Ballester F, Tardón A.
    TITLE: Annoyance Caused by Noise and Air Pollution during Pregnancy: Associated Factors and Correlation with Outdoor NO2 and Benzene Estimations.
    Int J Environ Res Public Health. 2015 Jun 18;12(6):7044-58. doi: 10.3390/ijerph120607044. PubMed PMID: 26095869; PubMed Central PMCID: PMC4483747.
  6. AUTHORS: Rodríguez-Dehli AC, Riaño Galán I, Fernández-Somoano A, Navarrete-Muñoz EM, Espada M, Vioque J, Tardón A.
    TITLE: Prevalence of vitamin d deficiency and insuffiency and associated factors in pregnant women of northern Spain.
    Nutr Hosp. 2015 Apr 1;31(4):1633-40. doi: 10.3305/nh.2015.31.4.8448. Spanish. PubMed PMID: 25795951.
  7. AUTHORS: Vizcaino E, Grimalt JO, Glomstad B, Fernández-Somoano A, Tardón A.
    TITLE: Gestational weight gain and exposure of newborns to persistent organic pollutants.
    Environ Health Perspect. 2014 Aug; 122(8):873-9. doi: 10.1289/ehp.1306758. Epub 2014 May 2. PubMed PMID: 24786842; PubMed Central PMCID: PMC4123021.
  8. AUTHORS: Vizcaino E, Grimalt JO, Fernández-Somoano A, Tardon A.
    TITLE: Transport of persistent organic pollutants across the human placenta.
    Environ Int. 2014 Apr; 65:107-15. doi: 10.1016/j.envint.2014.01.004. Epub 2014 Jan 28. PubMed PMID: 24486968.
  9. AUTHORS: Fernández-Somoano A, Tardon A.
    TITLE: Socioeconomic status and exposure to outdoor NO2 and benzene in the Asturias INMA birth cohort, Spain.
    J Epidemiol Community Health. 2014 Jan;68(1):29-36. doi: 10.1136/jech-2013-202722. Epub 2013 Sep 2. PubMed PMID: 23999377; PubMed Central PMCID: PMC3888634.
  10. AUTHORS: Fernández-Somoano A, Hoek G, Tardon A.
    TITLE: Relationship between area-level socioeconomic characteristics and outdoor NO2 concentrations in rural and urban areas of northern Spain.
    BMC Public Health. 2013 Jan 25; 13:71. doi: 10.1186/1471-2458-13-71. PubMed PMID: 23351567; PubMed Central PMCID: PMC3659019.
  11. AUTHORS: Miguel García-Villarino, Isolina Riaño-Galán, Ana Cristina Rodriguez-Dehli, Esther Vizcaino, Joan O. Grimalt, Adonina Tardón, Ana Fernández-Somoano.
    TITLE: Prenatal exposure to persistent organic pollutants and anogenital distance in children at 18 months.
    EN PRENSA. Paediatric and Perinatal Epidemiology.
  12. AUTHORS: Fernández-Somoano A, Álvarez-Avellón SM, Souto-García A, Vioque J, Navarrete-Muñoz EM, Tardón A.
    TITLE: Alcohol Consumption and Lung Cancer According to Ile349Val Polymorphism in ADH3 Gene: Beyond the Tobacco Smoking Effect.
    J Cancer. 2017 Jul 20; 8(12):2296-2302. doi: 10.7150/jca.18853. eCollection 2017. PubMed PMID: 28819433; PubMed Central PMCID: PMC5560148.
  13. AUTHORS: Álvarez-Avellón SM, Fernández-Somoano A, Navarrete-Muñoz EM, Vioque J, Tardón A.
    TITLE: Effect of alcohol and its metabolites in lung cancer: CAPUA study.
    Med Clin (Barc). 2017 Jun 21; 148(12):531-538. doi: 10.1016/j.medcli.2016.12.033. Epub 2017, Feb 22. English, Spanish. PubMed PMID: 28236470.
  14. AUTHORS: Tardon A.
    TITLE: Genetic polymorphisms and lung cancer risk.
    Med Clin (Barc). 2014 Aug 4; 143(3):113-4. doi: 10.1016/j.medcli.2013.12.004. Epub 2014 Jan 21. Spanish. PubMed PMID: 24456923.
  15. AUTHORS: Souto-García A, Fernández-Somoano A, Pascual T, Álvarez-Avellón SM, Tardón A.
    TITLE: Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study.
    Lung Cancer (Auckl). 2012 Nov 21; 3:69-78. doi: 10.2147/LCTT.S35287. eCollection 2012. PubMed PMID: 28210126; PubMed Central. PMCID: PMC5312605.
  16. AUTHORS: López-Cima MF, Alvarez-Avellón SM, Pascual T, Fernández-Somoano A, Tardón A.
    TITLE: Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias.
    BMC Cancer. 2012 Sep 27;12:433. doi: 10.1186/1471-2407-12-433. PubMed PMID: 23013535; PubMed Central PMCID: PMC3518149.
  17. AUTHORS: González-Arriaga P, Pascual T, García-Alvarez A, Fernández-Somoano A, López-Cima MF, Tardón A.
    TITLE: Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival.
    BMC Cancer. 2012 Mar 28; 12:121. doi: 10.1186/1471-2407-12-121. PubMed PMID: 22455335; PubMed Central PMCID: PMC3350430.
  18. AUTHORS: López-Cima MF, García-Pérez J, Pérez-Gómez B, Aragonés N, López-Abente G, Tardón A, Pollán M.
    TITLE: Lung cancer risk and pollution in an industrial region of Northern Spain: a hospital-based case-control study.
    Int J Health Geogr. 2011 Jan 25; 10:10. doi: 10.1186/1476-072X-10-10. PubMed PMID: 21266041; PubMed Central. PMCID: PMC3040690.
  19. AUTHORS: Leader A, Fernández-Somoano A, López-Cima MF, González-Arriaga P, Pascual T, Marrón MG, Tardón A.
    TITLE: Educational inequalities in quantity, duration and type of tobacco consumption among lung cancer patients in Asturias: epidemiological analyses.
    Psicothema. 2010 Nov; 22(4):634-40. PubMed PMID: 21044490.
  20. AUTHORS: Tardon A, Lee WJ, Delgado-Rodriguez M, Dosemeci M, Albanes D, Hoover R, Blair A.
    TITLE: Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control.
    2005 May; 16(4):389-97. Review. PubMed PMID: 15953981; PubMed Central PMCID: PMC1255936.
Principal Investigator Title Funding Body Participating Institutions Duration
PROJECT FISS-PI13/02429
Adonina Tardón García Environmental contamination through exposure to persistent toxic substances and effects upon children’s physical, visual and cognitive development Health Research Fund. Instituto de Salud Carlos III 30-09-2013 to 31-06-2018
Principal Investigator Title Funding Body Participating Institutions Co-Investigators Number of Researchers Duration
PROJECT FIS-FEDER PI15/00069
Francisco Javier Llorca Díaz Integration of genetic big data and clinical data: breast cancer survival in the MCC-Spain study. Instituto de Salud Carlos III Universidad de Cantabria. Project conducted in: IUOPA, Universidad de Oviedo, Asturias, Spain Guillermo Fernández Tardón 6 01-01-2016 to 30-06-2019
Principal Investigator Title Funding Body Participating Researchers Reference No Duration
PROJECT FIS-FEDER PI18/01313
Ana Fernández Somoano Evolution of socioeconomic and environmental inequalities in the geographical distribution of mortality in the main cities of Asturias (1996-2015): MEDEA3 Health Research Fund. Instituto de Salud Carlos III FISS-PI18/01313 01-09-2018 to 01-10-2021
AECC (Spanish Association Against Cancer) GRANTS FOR TRANSLATIONAL GROUPS 2018
Adonina Tardón García: PI for the Asturian node . Víctor Moreno Aguado PI Coordinator Moving towards precision medicine in cancer prevention through genetic and metabolomic screening “AECC Grants for Coordinated Translational Groups 2018” from the Fundación Científica AECC AECC 2018 02-07-2018 to 30-09-2021
FIS-FEDER PI18/01237 PROJECT
Jesus Ibarluzea Maurolagoitia INMA-Ado-Urban . Urban environment, psychosocial surroundings and mental development in childhood and preadolescence Health Research Fund. Instituto de Salud Carlos III Guillermo Fernández Tardón and Rafael Vicente Castro Delgado FISS-PI18/01237 01-09-2018 to 01-10-2021
Principal Investigator Title Funding Body Participating Institutions Duration Public Funding
REFERENCE. GROUP 53. CIBERESP
Adonina Tardón García CIBERESP (Network Centre for Biomedical Research: Epidemiology and Public Health) Ministerio de Sanidad y Consumo. Instituto de Salud Carlos III 01-01-2007 – Ongoing
PUBLIC GRANT FOR THE UNIVERSIDAD DE OVIEDO IN HEALTH AND THE ENVIRONMENT
Adonina Tardón García Public grant for the Universidad de Oviedo in health and the environment. Consejería de Sanidad. Gobierno del Principado de Asturias. Preventive Medicine and Public Health Section. Universidad de Oviedo. March 2017 to 31-12-2018 €40,000 / year
Partnership between the Ayuntamiento de Gijón (Gijón City Council) and the Universidad de Oviedo on the PROJECT TO SET UP THE INMA GIJÓN COHORT
Adonina Tardón García Public grant for the Universidad de Oviedo to set up the GIJÓN INMA COHORT. Ayuntamiento de Gijón Preventive Medicine and Public Health Section. Universidad de Oviedo. March 2017 to 31-12-2017 €57,000
PhD Student Title Date of Viva Centre
María Del Mar Martínez Suárez Infection of surgical wounds: rate of occurrence and assessment in seven hospitals in Asturias. (2007-2015). 06-07-2018 Department of Medicine. Universidad de Oviedo
Mirko Peter Neumann Mutations of the TP53 gene in lung cancer patients with occupational exposure to silica and the application of the gene in certain intracellular molecular pathways. 04-07-2017
Carmen Natal Ramos Effectiveness and efficiency of population-level breast cancer screening programmes. 27-06-2017
Ana María Blanco Badillo The expression of MUC1: its predictive and prognostic value in lung adenocarcinomas. 18-12-2015
Ana Souto García Polymorphism in cell-cycle regulatory genes and lung cancer risk. 23-06-2015
Ana Cristina Rodríguez Dehli The prevalence of vitamin D deficiency and insufficiency and associated factors in gestation and early childhood in northern Spain. 20-07-2015 Universidad de Oviedo
Sara María Álvarez Avellón Polymorphism in alcohol, acetaldehyde and folate metabolism genes and lung cancer risk. 13-11-2015 Universidad de Oviedo Outstanding PhD Award
Ana Fernández Somoano Exposure to air pollution in the INMA-Asturias cohort of pregnant women.
International Honours
28-11-2013 Universidad de Oviedo Outstanding PhD Award
José Antonio Cernuda Martínez The perceived training, theoretical knowledge and practical skills in accident and emergency medicine of primary healthcare professionals in Asturias. 03-06-2016 Department of Medicine. Universidad de Oviedo
  • A phase 3, open-label, randomised, multicentre, 12 months, efficacy and safety study of weekly MOD-4023 compared to daily genotropin® therapy in pre-pubertal children with growth hormone deficiency (EUDRACT NUMBER: 2016-003874-42 CODE: CP-4-006. SPONSOR: OPKO Biologics Ltd. PROTOCOL: V. 1.0 29 Nov 2016). PI Isolina Riaño Galán at Hospital Universitario Central de Asturias.
  • Phase 4 Study: “Observational study until adult height of a cohort of subjects born small for gestational age (SGA) and treated with a growth hormone ” (Code SER-GH-2005-01) (sponsored by Merck Serono Spain).
  • Phase 4 Study: “Prospective, single-cohort, multicentre observational long-term study in short children born small for gestational age (SGA) after treatment with Saizen® (Code EMR 200098-008 / SALTO) (sponsored by Merck Serono SA).